Acquired qualitative platelet disorders.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D001791:Blood Platelet Disorders / Q000209:etiology* / Q000628:therapy; D001792:Blood Platelets / Q000032:analysis / Q000187:drug effects / Q000276:immunology / Q000502:physiology; D001793:Blood Preservation; D001803:Blood Transfusion; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D004211:Disseminated Intravascular Coagulation / Q000097:blood; D006487:Hemostasis; D006801:Humans; D007938:Leukemia / Q000097:blood; D008107:Liver Diseases / Q000097:blood; D009196:Myeloproliferative Disorders / Q000097:blood; D011289:Preleukemia / Q000097:blood; D011696:Purpura, Thrombocytopenic / Q000209:etiology; D014511:Uremia / Q000097:blood; D014842:von Willebrand Diseases / Q000097:blood
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000244:Adenosine Diphosphate